Sarah Kiely | Director, Investor Relations |
Mark Enyedy | Chief Executive Officer |
Anna Berkenblit | Chief Medical Officer |
Dave Johnston | Chief Financial Officer |
Rich Gregory | Chief Scientific Officer |
Biren Amin | Jefferies |
Michael Schmidt | Leerink |
Boris Peaker | Cowen |
Mara Goldstein | Cantor Fitzgerald |
Andy Hsieh | William Blair |
John Newman | Canaccord |
Good day and welcome to today’s ImmunoGen Conference Call covering operating and financial results for the Third Quarter 2017. Today’s call is being recorded. At this time, I would like to turn the conference over to Sarah Kiely, Director of Investor Relations for introductions. Please go ahead.
Thank you.